Hepatitis B virus (HBV) infection is a world wide public health problem of major concern.
HBV infection may lead to chronic liver disease, including cirrhosis and hepatocellular …

Viral hepatitis B is a leading cause of acute and chronic liver disease worldwide, including
cirrhosis and hepatocellular carcinoma. Vaccination is the most effective measure for …

Hepatitis B is a disease that affects people throughout the world, and over 200 million are
persistent carriers of the hepatitis B virus (HBV). The chronic sequelae of this infection …

Hepatitis B virus infection is a global health problem. Worldwide, about 360 million people
are chronically infected with the virus. They continue to spread the virus to others and are …

Hepatitis B virus (HBV) is a major cause of morbidity and mortality with a disproportionate
impact on Asia and Africa. Current guidelines recommend screening at-risk populations for …

The Viral Hepatitis Prevention Board (VHPB) organized an international meeting in Milan in
November 2011 on the question of whether completing a course of hepatitis B vaccination …

Hepatitis B is a disease of global importance, with> 300 million carriers of the virus world-
wide. Hepatitis B virus (HBV) is the cause of up to 80% of cases of primary liver cancer, the …

The hepatitis B virus (HBV) has infected more than 2000 million persons alive today and 350
million persons are chronically infected carriers of the virus, at high risk of death from active …

Abstract Hepatitis B (HB) virus (HBV) infection, which causes liver cirrhosis and
hepatocellular carcinoma, is endemic worldwide. Hepatitis B vaccines became commercially …

Worldwide, hepatitis B virus (HBV) is the most common among those hepatitis viruses that
cause chronic infections of the liver in humans, and it represents a global public health …